Crossmark

Characterization of the mucosal microbiota in patients with nodular lymphoid hyperplasia with concurrent irritable bowel syndrome compared to healthy controls

Crossref DOI link: https://doi.org/10.1007/s11033-022-07974-1

Published Online: 2022-10-31

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Salarieh, Naghmeh

Emami Meibodi, Armitasadat

Alipour, Samira

Azimirad, Masoumeh

Looha, Mehdi Azizmohammad

Asadzadeh Aghdaei, Hamid

Yadegar, Abbas https://orcid.org/0000-0002-2135-7581
Shahrokh, Shabnam

Zali, Mohammad Reza
Funding

Funding for this research was provided by:

Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran (RIGLD 1177)
License Information

Text and Data Mining valid from 2022-10-31

Version of Record valid from 2022-10-31
More Information

Article History

Received: 3 July 2022

Accepted: 21 September 2022

First Online: 31 October 2022

Declarations

:

: The authors declare that they have no conflicts of interest.

: Ethical clearance for conducting this study was obtained from the Institutional Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases at Shahid Beheshti University of Medical Sciences (Project No. IR.SBMU.MSP.REC.1400.671).

: Informed consent was obtained from all individual participants included in the study before sample collection.

Document is current

Any future updates will be listed below